Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT06851663 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06851663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06851663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trop2-targeted immunoPET Imaging of Solid Tumors
Lead sponsor
RenJi Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
December 23, 2024
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, cervical cancer, cholangiocarcinoma, endometrial cancer, head and neck cancer, liver cancer, lung cancer, nasopharyngeal cancer, ovarian cancer, prostate cancer, solid carcinoma, solid tumor, thyroid cancer, uroepithelial carcinoma